Less than 40% of hypertensive patients in treatment achieved the objectives set out by your health care provider.
17 may: World hypertension day.
– innovative treatment of renal sympathetic denervation is able to improve control in patients with resistant hypertension figures ”, according to Dr. GarcÃa Donaire, expert in cardiovascular risk of Hospital USP San Camilo de Madrid
Madrid, 2012-may high blood pressure (hypertension) is the risk factor more important when developing cardiovascular diseases such as myocardial infarctionstroke, kidney failure or cardiac arrhythmias, advises Dr. GarcÃa Donaire, specialist in cardiovascular risk in Hospital USP San Camilo in Madrid. Also, relates to a worse prognosis they are associated with any other pathology.
Its prevalence in Spain is growing progressively in recent years, around 40% of the current population, more than 8 million people, of which a significant proportion is unknown it is hypertensive and less than 40% of those who receive treatment reaches the objectives set by your doctor.
Una de las principales razones para explicar esta situación, comenta el especialista, es la escasez o ausencia de síntomas relacionados con la HTA, que suele cursar asintomática hasta fases avanzadas años más tarde, siendo la prevención mediante controles periódicos de salud la única y más eficiente forma de diagnóstico en fases tempranas de HTA.
Only a small percentage (8-10%) of the hypertensive patients have a cause which justifies the increase in blood pressure, while the rest is of unknown origin, by what is called essential hypertension, although progress being made in the knowledge of the genetic origin for their early detection.
The treatment of hypertensive patients should be based on the combination of changes in lifestyle – reduce the consumption of salt and saturated dietary fat or increase physical exercise – and medical treatment. Currently there are modern and effective antihypertensive monotherapy and combination of several drugs which should control the disease in the majority of cases.
La principal novedad terapéutica viene derivada del tratamiento de los pacientes con HTA refractaria o resistente, que no se controlan con las medidas previas; recientemente se han publicado datos de alto interés sobre la denervación simpática renal por vía endovascular, consistente en aplicar energía de radiofrecuencia en las arterias renales, which is able to improve control of the above-mentioned high-risk population figures ”, concludes Dr. GarcÃa Donaire.
About USP hospital
Founded in 1998 and headquartered in Madrid, USP hospital is the first hospital private group in the Spanish market. Currently, USP hospital boasts a network of 12 hospitals, 23 health centres and 4,000 doctors annually serving more than two million patients. In 2011 the company registered 327.261 clinical stays, 125.076 surgery, 9.952 births and 506.759 er.
